يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Carlos Alexandre Fedrigo"', وقت الاستعلام: 1.81s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, APH - Methodology, CCA - Cancer biology and immunology, Radiotherapy, Cancer Center Amsterdam, Other departments, Radiation Oncology, CCA - Cancer Treatment and quality of life, Neurosurgery, AGEM - Digestive immunity, Medical oncology laboratory

    المصدر: BMC Cancer, 17:204. BioMed Central Ltd
    Narayan, R S, Fedrigo, C A, Brands, E, Dik, R, Stalpers, L J A, Baumert, B G, Slotman, B J, Westerman, B A, Peters, G J & Sminia, P 2017, ' The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures ', BMC Cancer, vol. 17, no. 1, 204 . https://doi.org/10.1186/s12885-017-3193-9
    BMC Cancer
    BMC cancer, 17(1). BioMed Central
    BMC Cancer, 17(1):204. BioMed Central

  4. 4

    المساهمون: Radiotherapie, RS: GROW - School for Oncology and Reproduction, Radiation Oncology, CCA - Innovative therapy, Cancer Center Amsterdam, Radiotherapy

    المصدر: Current Pharmaceutical Design, 19(5), 951-957. Bentham Science Publishers Ltd.
    Narayan, R S, Fedrigo, C A, Stalpers, L J A, Baumert, B G & Sminia, P 2013, ' Targeting the Akt-pathway to Improve Radiosensitivity in Glioblastoma ', Current Pharmaceutical Design, vol. 19, no. 5, pp. 951-957 . https://doi.org/10.2174/138161213804547286
    Current Pharmaceutical Design, 19(5), 951-957. Bentham Science Publishers B.V.
    Current pharmaceutical design, 19(5), 951-957. Bentham Science Publishers B.V.
    Narayan, R S, Fedrigo, C A, Stalpers, L J A, Baumert, B G & Sminia, P 2013, ' Targeting the Akt-pathway to improve radiosensitivity in glioblastoma ', Current Pharmaceutical Design, vol. 19, no. 5, pp. 951-7 .

  5. 5
  6. 6